Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda.
Anthere MurangwaKanan T DesaiJulia C GageGad MurenziPatrick TuyisengeFaustin KanyabwishaAimable MusafiliGallican KubwimanaLéon MutesaKathryn AnastosHae-Young KimPhilip E CastlePublished in: African journal of laboratory medicine (2022)
Overall, there was good to excellent agreement between the Xpert and AmpFire when testing hrHPV types among women living with HIV. AmpFire was more likely to test extra cases of HPV16, the most carcinogenic HPV type, but the clinical meaning of detecting additional HPV16 infections remains unknown.